The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
Open accessAbstract
Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease, especially on the need for surgery, is not known. The aim of this study was to assess the evolution of the need for surgery in Crohn’s disease during the last 25 years. Patients and Methods: The medical charts of 2573 patients were reviewed retrospectively. The use of immunosuppressants (azathioprine or methotrexate), the need for intestinal resection, and the occurrence of intestinal complications were assessed using Kaplan-Meier analysis in five consecutive cohorts of patients defined by the date of diagnosis of Crohn’s disease (1978–82; 1983–87; 1988–92; 1993–97; 1998–2002). Results: In 565 patients seen in the authors’ unit within the first three months after diagnosis, characteristics of Crohn’s disease at diagnosis did not differ from one cohort to another. The five year cumulative probability to receive immunosuppressants increased from 0 in the 1978–82 cohort to 0.13, 0.25, 0.25, and 0.56 in the 1983–87, 1988–92, 1993–97, and 1998–2002 cohorts, respectively (p<0.001). Concomitantly, the cumulative risk of intestinal resection remained unchanged (from 0.35 to 0.34 at five years; p = 0.81). The cumulative risk of developing a stricturing or a penetrating intestinal complication remained also unchanged. Similar results were obtained in the 2008 patients seen during the same period who were referred to us more than three months after diagnosis. Conclusion: Although immunosuppressants have been used more frequently over the last 25 years, there was no significant decrease of the need for surgery, or of intestinal complications of Crohn’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Classification of Inflammatory Bowel Disease
Lennard-Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,011
Long-Term Evolution of Disease Behavior of Crohn's Disease
Cosnes, J., Cattan, S., Blain, A., Beaugerie, L., Carbonnel, F., Parc, R., & Gendre, J.-P. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200207000-00002 · Cited by 1,346
Self-citationGasche, C., Scholmerich, J., Brynskov, J., DʼHaens, G., Hanauer, S. B., Irvine, J. E., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00002 · Cited by 1,134
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis
Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M., & Braganza, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391001 · Cited by 954
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
Pearson, D. C., May, G. R., Fick, G. H., & Sutherland, L. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00009 · Cited by 950
Relation between Mutations of the Cystic Fibrosis Gene and Idiopathic Pancreatitis
Cohn, J. A., Friedman, K. J., Noone, P. G., Knowles, M. R., Silverman, L. M., & Jowell, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391002 · Cited by 928
Colombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., Zinsmeister, A. R., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.047 · Cited by 899
Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859
Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987
Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Izumi, S., et al. (1994) · Radiation Research · doi:10.2307/3578892 · Cited by 779
Markowitz, J., Grancher, K., Kohn, N., Lesser, M., & Daum, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.18144 · Cited by 716
Brown, S. L., Greene, M. H., Gershon, S. K., Edwards, E. T., & Braun, M. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10679 · Cited by 655
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096316 · Cited by 501
Gorry, M., Gabbaizedeh, D., Furey, W., Gates, L., Preston, R., Aston, C., Zhang, Y., Ulrich, C., Ehrlich, G., & Whitcomb, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322498 · Cited by 478
Wallace, J. L., MacNaughton, W. K., Morris, G. P., & Beck, P. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90760-9 · Cited by 435
Clinical features and natural history of Crohn's disease
Mekhjian, H. S., Switz, D. M., Melnyk, C. S., Rankin, G. B., & Brooks, R. K. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90389-5 · Cited by 406
Effects of cigarette smoking on the long-term course of Crohn's disease
Cosnes, J., Carbonnel, F., Beaugerie, L., Le Quintrec, Y., & Gendre, J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566589 · Cited by 389
Self-citationFatty Infiltration of Liver in Hyperlipidemic Patients
Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B., & Minuk, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005661516165 · Cited by 360
Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Mercenier, A., Pavan, S., & Pot, B. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392224 · Cited by 342
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.
Stanghellini, V, Camilleri, M., & Malagelada, J. R. (1987) · Gut · doi:10.1136/gut.28.1.5 · Cited by 323
Ljung, T., Karlén, P., Schmidt, D., Hellström, P. M., Lapidus, A., Janczewska, I., Sjöqvist, U., & Löfberg, R. (2004) · Gut · doi:10.1136/gut.2003.018515 · Cited by 313
Azathioprine for maintenance of remission in Crohn's disease
Pearson, D., May, G., Fick, G., & Sutherland, L. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067 · Cited by 304
Crohn's disease: Transmission electron microscopic studies
Dvorak, A. M., Monahan, R. A., Osage, J. E., & Dickersin, G. R. (1980) · Human Pathology · doi:10.1016/s0046-8177(80)80072-4 · Cited by 298
Gasche, C., Scholmerich, J., Brynskov, J., D'Haens, G., Hanauer, S. B., Irvine, E. J., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780060103 · Cited by 287
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction: Figure 1
De Giorgio, R., Sarnelli, G., Corinaldesi, R., & Stanghellini, V (2004) · Gut · doi:10.1136/gut.2004.043968 · Cited by 281
Symptoms of irritable bowel syndrome in ulcerative colitis in remission
Isgar, B., Harman, M., Kaye, M. D., & Whorwell, P. J. (1983) · Gut · doi:10.1136/gut.24.3.190 · Cited by 274
Kimura, H., Hokari, R., Miura, S., Shigematsu, T., Hirokawa, M., Akiba, Y., Kurose, I., Higuchi, H., Fujimori, H., Tsuzuki, Y., et al. (1998) · Gut · doi:10.1136/gut.42.2.180 · Cited by 250
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
Lewis, J. D., Schwartz, J. S., & Lichtenstein, G. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70353-2 · Cited by 242
Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults
Mann, S. D., Debinski, H. S., & Kamm, M. A. (1997) · Gut · doi:10.1136/gut.41.5.675 · Cited by 235
Tropical calcific pancreatitis: Strong association with SPINK1 trypsin inhibitor mutations
Bhatia, E., Choudhuri, G., Sikora, S. S., Landt, O., Kage, A., Becker, M., & Witt, H. (2002) · Gastroenterology · doi:10.1053/gast.2002.36028 · Cited by 218
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine
D'Haens, G., Geboes, K., & Rutgeerts, P. (1999) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(99)80017-0 · Cited by 216
Studies on the mechanism of bowel disturbance in ulcerative colitis
Rao, S. S. C., Read, N. W., Brown, C., Bruce, C., & Holdsworth, C. D. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90554-3 · Cited by 215
Nitrate in Public Water Supplies and the Risk of Colon and Rectum Cancers
De Roos, A. J., Ward, M. H., Lynch, C. F., & Cantor, K. P. (2003) · Epidemiology · doi:10.1097/01.ede.0000091605.01334.d3 · Cited by 207
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway
Bajzar, L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2511 · Cited by 204
The relationship between infliximab treatment and lymphoma in Crohn's disease
Bickston, S. J., Lichtenstein, G. R., Arseneau, K. O., Cohen, R. B., & Cominelli, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70294-5 · Cited by 203
Chandak, G. R., Idris, M. M., Reddy, D. N., Bhaskar, S., Sriram, P. V. J., & Singh, L. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.347 · Cited by 167
Schneider, A. T., Suman, A., Rossi, L., Barmada, M. M., Beglinger, C., Parvin, S., Sattar, S., Ali, L., Khan, A. K. A., Gyr, N. E., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36059 · Cited by 155
Nonalcoholic Fatty Liver Disease
Jorgensen, R. A. (2003) · Gastroenterology Nursing · doi:10.1097/00001610-200307000-00003 · Cited by 148
Childhood malignancies in Germany—methods and results of a nationwide registry
Kaatsch, P., Haaf, G., & Michaelis, J. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00091-7 · Cited by 142
Namour, F., Olivier, J. L., Abdelmouttaleb, I., et al. (2001) · Blood · doi:10.1182/blood.v97.4.1092 · Cited by 134
Disturbed Autonomic Nerve Function in Patients with Crohn's Disease
Lindgren, S. C., Lilja, B., Rosén, I., & Sundkvist, G. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108996495 · Cited by 129
Obermeier, F., Dunger, N., Strauch, U., Grunwald, N., HERFARTH, H., Schölmerich, J., & Falk, W. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02288.x · Cited by 125
Review Article: Inherited Thrombophilia in Inflammatory Bowel Disease
Papa, A., Danese, S., Grillo, A., Gasbarrini, A., & Gasbarrini, A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07491.x · Cited by 112
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab
Mahé, E., Descamps, V., Grossin, M., Fraitag, S., & Crickx, B. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05384.x · Cited by 107
Guédon, C., Cam-Duche, V. L., Lalaude, O., Ménard, J.-F., Lerebours, E., & Borg, J. Y. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03797.x · Cited by 87
Bruix, J., SALA, M., & LLOVET, J. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50084-3 · Cited by 76
Crohn's disease: step up or top down therapy
Hanauer, S. B. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2003.0361 · Cited by 71
Cancer Incidence in the Atomic Bomb Survivors.
Mabuchi, K. (1993) · Cited by 68
Mirvish, S. S. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.595 · Cited by 64
Nitrite from inflammatory cells—A cancer risk factor in ulcerative colitis?
Roediger, W. E. W., Lawson, M. J., & Radcliffe, B. C. (1990) · Diseases of the Colon & Rectum · doi:10.1007/bf02139219 · Cited by 61
Roddy, E. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.10.1194 · Cited by 57
Abnormal Motility of the Small Intestine in Ulcerative Colitis
Manousos, O. N., & Salem, S. (2009) · Gastroenterologia · doi:10.1159/000202102 · Cited by 43
Classification of the sequelae of bowel resection for Crohn's disease
Cosnes, J., de Parades, V., Carbonnel, F., et al. (1994) · British journal of surgery · doi:10.1002/bjs.1800811122 · Cited by 41
Self-citationEvolving Treatment Strategies for Inflammatory Bowel Disease
Hanauer, S. B., & Dassopoulos, T. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.299 · Cited by 36
Reid, G., Guarner, F., Gibson, G. R., Tompkins, T. A., Gill, H., Rowland, I. R., Rastall, B., Pot, B., & Sanders, M. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.052 · Cited by 26
Cited by
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
Ravikumar, B., Sarkar, S., Davies, J. E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z. W., Jimenez-Sanchez, M., Korolchuk, V. I., Lichtenberg, M., Luo, S., et al. (2010) · Physiological Reviews · doi:10.1152/physrev.00030.2009 · Cited by 1,727
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
D'Haens, G., Baert, F., van Assche, G., Caenepeel, P., Vergauwe, P., Tuynman, H., De Vos, M., van Deventer, S., Stitt, L., Donner, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60304-9 · Cited by 1,231
Beaugerie, L., Brousse, N., Bouvier, A. M., Colombel, J. F., Lémann, M., Cosnes, J., Hébuterne, X., Cortot, A., Bouhnik, Y., Gendre, J. P., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61302-7 · Cited by 1,115
Self-citationThe burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
Metadata
- Authors
- Cosnes, J., Nion-Larmurier, I., Beaugerie, L., Afchain, P., Tiret, E., & Gendre, J.-P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-01-11
- Volume
- 54
- Issue
- 2
- Pages
- 237-241
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2106733239
- Cited by
- 657
- References
- 61
- FWCI
- 18.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.